For once, Pfizer's Covid pill fails in a trial — but only after seeking a much broader population - Endpoints News

Pfizer's Covid-19 pill, which has boasted overwhelmingly strong data in protecting certain high-risk people with Covid-19 from ending up in the hospital or dying, now has at least one minor weakness. The company reported last Friday that in a trial of almost …

Pfiz­er’s Covid-19 pill, which has boast­ed over­whelm­ing­ly strong da­ta in pro­tect­ing cer­tain high-risk peo­ple with Covid-19 from end­ing up in the hos­pi­tal or dy­ing, now has at least one m… [+2735 chars]

full article...